| 1 | 2650-07-9 | 3-Methyl-4-(phenylazo)-2-pyrazolin-5-one | C10H10N4O | 202.2126 | | |
| 2 | 2650-14-8 | 3-Bromo-4-hydroxy-2H-1-benzopyran-2-one | C9H5BrO3 | 241.04 | | |
| 3 | 2650-15-9 | 2H-1-Benzopyran-2-one, 4-hydroxy-7,8-dimethoxy- | C11H10O5 | 222.1941 | | |
| 4 | 2650-17-1 | xylenecyanol ff | C25H27N2NaO6S2 | 538.61 | 295°C | Soluble in water. |
| 5 | 2650-18-2 | Food Blue 2 | C37H39N3O9S3 | 765.91 | 283°C (dec.)(lit.) | 1000g/L at 24.3℃ |
| 6 | 2650-30-8 | sodium 3,5,5-trimethylhexanoate | C9H17NaO2 | 180.21985 | | 644g/L at 23℃ |
| 7 | 2650-34-2 | 6,10b-Methano-10bH-furo[2,3-c]pyrrolo[1,2-a]azepin-2(4H)-one, 5,6,8,9,10,10a-hexahydro-, (6R,10aR,10bS)- | C12H15NO2 | 205.25 | | |
| 8 | 2650-35-3 | norsecurinine | C12H13NO2 | 203.24 | | |
| 9 | 2650-36-4 | DUBIRHEINE | C22H23NO6 | 397.42 | 236～237℃ | |
| 10 | 2650-40-0 | 3,3,5,5-TETRAMETHYLCYCLOHEXANOL | C10H20O | 156.27 | | |
| 11 | 2650-44-4 | 1-NAPHTHYL PHOSPHATE MONOSODIUM SALT MONOHYDRATE | C10H10NaO5P | 264.15 | | |
| 12 | 2650-47-7 | sorbose-1-phosphate | C6H13O9P | 260.14 | | |
| 13 | 2650-50-2 | Trimethylpropylammonium Bromide | C6H16BrN | 182.10194 | 238°C(dec.)(lit.) | |
| 14 | 2650-51-3 | N,N,N-trimethylbutan-1-aminium bromide | C7H18N.Br | 196.13 | 196 °C | |
| 15 | 2650-53-5 | hexyltrimethylammonium bromide | C9H22BrN | 224.18 | 182-184°C | almost transparency |
| 16 | 2650-64-8 | N-Carbobenzyloxy-L-glutamine | C13H16N2O5 | 280.28 | 134-138°C(lit.) | |
| 17 | 2650-65-9 | H-GLN-GLY-OH | C7H13N3O4 | 203.2 | | |
| 18 | 2650-66-0 | (S)-Benzyl N-(1,5-diamino-1,5-dioxopentan-2-yl)carbamate | C13H17N3O4 | 279.29 | 193-194 °C(Solv: ethanol (64-17-5)) | |
| 19 | 2650-67-1 | Z-GLN-OME | C14H18N2O5 | 294.3 | | |
| 20 | 2650-69-3 | H-GLY-GLN-GLY-OH | C9H16N4O5 | 260.25 | | |
| 21 | 2650-74-0 | L-Glutamine, N-(2-hydroxyethyl)- | C7H14N2O4 | 190.19706 | | |
| 22 | 2650-77-3 | Ethyltrimethylammonium bromide | C2H5(CH3)3NBr | 168.08 | | |
| 23 | 26500-16-3 | Pentacarbonyl(trimethylsilyl)manganese | C8H19MnO5Si | 278.257009 | | |
| 24 | 2650001-62-8 | Ensartinib Impurity 22 | C26H27CI2FN6O3 | 561.44 | | |
| 25 | 2650002-45-0 | Glucose Impurity 6 | | | | |
| 26 | 2650011-33-7 | Fezolinetant Impurity 52 | | | | |
| 27 | 2650022-03-8 | Fezolinetant Impurity 15 | | | | |
| 28 | 2650022-11-8 | Nafcillin Sodium Hydrate | | | | |
| 29 | 2650024-47-6 | (2S,5S)-7-oxo-2-(2,7-diazaspiro[3.5]nonane-2-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C14H22N4O6S | 374.41 | | |
| 30 | 2650026-99-4 | Oxymetazoline Impurity 6 Hydrochloride | | | | |
| 31 | 2650027-99-7 | Fezolinetant Impurity 17 | | | | |
| 32 | 2650029-77-7 | Ensartinib Impurity 12 | C26H27CI2FN6O3 | 561.44 | | |
| 33 | 2650032-03-2 | (R)-pyrrolidin-3-yl (2S,5S)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxylate | C11H17N3O7S | 335.33 | | |
| 34 | 2650036-65-8 | (S)-isoxazolidin-4-yl (2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxylate | C10H15N3O8S | 337.3 | | |
| 35 | 2650041-41-9 | Samidorphan Impurity 3 | C22H28N2O4 | 384.48 | | |
| 36 | 2650042-20-7 | Fazamorexant Impurity 19 | | | | |
| 37 | 2650043-07-3 | Lenvatinib Impurity 156 | | | | |
| 38 | 2650043-39-1 | Bexagliflozin Impurity 27 | | | | |
| 39 | 2650046-18-5 | Naphthoic Acid Impurity 44 | | | | |
| 40 | 2650046-72-1 | Naftifine Impurity 3 Monomer | | | | |
| 41 | 2650049-35-5 | Naphthoic Acid Impurity 45 | | | | |
| 42 | 2650050-02-3 | (2S,5S)-2-(azetidin-3-ylcarbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C10H16N4O6S | 320.32 | | |
| 43 | 2650050-13-6 | Relebactam Impurity 13 | | | | |
| 44 | 2650050-32-9 | (2S,5R)-7-oxo-2-(piperazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C11H18N4O6S | 334.35 | | |
| 45 | 2650053-35-1 | Fezolinetant Impurity 57 | | | | |
| 46 | 2650055-28-8 | Fezolinetant Impurity 49 | | | | |
| 47 | 2650057-51-3 | Fezolinetant Impurity 20 | | | | |
| 48 | 2650058-03-8 | Fezolinetant Impurity 62 | | | | |
| 49 | 2650058-56-1 | sodium (2R,5S)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C7H12N3NaO5S | 273.24 | | |
| 50 | 2650063-31-1 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-[2-(3-azetidinylcarbonyl)hydrazide], (2R,5S)-rel- | C11H17N5O7S | 363.35 | | |
| 51 | 2650063-77-5 | Fezolinetant Impurity 54 | | | | |
| 52 | 2650064-79-0 | Naphthoic Acid Impurity 46 | | | | |
| 53 | 2650065-39-5 | NAFTOPIDILHYDROCHLORIDE | | | | Soluble in DMSO. Also soluble in ethanol. Insoluble in water. |
| 54 | 2650066-35-4 | PF-06821497 Impurity 9 | C23H26Cl2N2O5 | 481.37 | | |
| 55 | 2650070-17-8 | Fezolinetant Impurity 48 | | | | |
| 56 | 2650073-66-6 | MED6-189 | C17H26N2O | 274.4 | | |
| 57 | 2650074-56-7 | 2650074-56-7 | C19H17NO4 | 323.34 | | |
| 58 | 2650078-30-9 | (R)-3-(4-Phenoxyphenyl)-1-[1-(vinylsulfonyl)-3-piperidyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine | | | | |
| 59 | 2650079-59-5 | Afacifenacin Impurity 7 | | | | |
| 60 | 2650081-97-1 | Fezolinetant Impurity 47 | | | | |
| 61 | 2650084-79-8 | Rodatristat Impurity 84 | | | | |
| 62 | 2650087-57-1 | sodium (2S,5R)-2-(2-(azetidine-3-carbonyl)hydrazine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate | C11H18N5NaO7S | 387.34 | | |
| 63 | 2650088-70-1 | ML377 | | | | |
| 64 | 26501-31-5 | 4,5-Acridinediol | C13H9NO2 | 211.22 | | |
| 65 | 26501-54-2 | Tetrabutylammonium Nitrite | C16H36N2O2 | 288.47 | 99-103°C | |
| 66 | 26501-80-4 | 1,4,6,7,8,8-Hexachloro-1,3a,4,6,7,7a-hexahydro-4,7-methanoisobenzofuran-5(3H)-one | C9H6Cl6O2 | 358.86 | | |
| 67 | 26501-83-7 | 5-methyl-furan-3-carboxylic acid ethyl ester | C8H10O3 | 154.16 | | |
| 68 | 2650101-18-9 | Fazamorexant Impurity 53 | | | | |
| 69 | 2650101-43-0 | Fazamorexant Impurity 18 | | | | |
| 70 | 2650101-49-6 | Fazamorexant Impurity 31 | | | | |
| 71 | 2650112-29-9 | Fazamorexant Impurity 63 | | | | |
| 72 | 2650114-44-4 | Fazamorexant Impurity 48 | | | | |
| 73 | 2650115-54-9 | Relebactam Impurity 31 | | | | |
| 74 | 2650122-15-7 | (2S,5S)-7-oxo-2-(((R)-pyrrolidin-3-yl)carbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C11H18N4O6S | 334.35 | | |
| 75 | 2650122-24-8 | Relebactam Impurity 30 | | | | |
| 76 | 2650125-06-5 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-(4-pyrazolidinyl) ester, (2R,5R)-re l | C10H16N4O7S | 336.32 | | |
| 77 | 2650127-84-5 | Relebactam Impurity 25 | | | | |
| 78 | 2650128-03-1 | (2S,5R)-2-((S)-3-aminopyrrolidine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C11H18N4O6S | 334.35 | | |
| 79 | 2650129-34-1 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-(3-azetidinyl) ester, (2R,5R)-re l- | C10H15N3O7S | 321.31 | | |
| 80 | 2650129-39-6 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-(2-aminoethyl) ester, (2R,5R)-rel- | C9H15N3O7S | 309.3 | | |
| 81 | 2650129-77-2 | Fazamorexant Impurity 21 | | | | |
| 82 | 2650130-98-4 | (S)-pyrrolidin-3-yl (2S,5S)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxylate | C11H17N3O7S | 335.33 | | |
| 83 | 2650131-17-0 | (R)-isoxazolidin-4-yl (2S,5R)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxylate | C10H15N3O8S | 337.3 | | |
| 84 | 2650132-77-5 | (2S,5S)-2-(methyl(piperidin-4-yl)carbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C13H22N4O6S | 362.4 | | |
| 85 | 2650136-57-3 | Ensartinib Impurity 10 | C26H27CI2FN6O3 | 561.44 | | |
| 86 | 2650136-83-5 | Fezolinetant Impurity 6 | | | | |
| 87 | 2650138-16-0 | Nalbuphine Hydrochloride | | | | |
| 88 | 2650159-27-4 | Fezolinetant Impurity 31 | | | | |
| 89 | 2650161-88-7 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-[(4R)-hexahydro- 1H-azepin-4-yl] ester, (2R,5R)-rel- | C13H21N3O7S | 363.39 | | |
| 90 | 2650165-40-3 | Fezolinetant Impurity 27 | | | | |
| 91 | 2650167-79-4 | Naphthoic Acid Impurity 47 | | | | |
| 92 | 2650168-94-6 | Ensartinib Impurity 14 | C25H25CI2FN6O3 | 547.71 | | |
| 93 | 2650176-25-1 | 2-(1H-Imidazol-4-yl)propan-1-amine hydrochloride | C6H12ClN3 | 161.63 | | |
| 94 | 2650179-56-7 | 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-(4-piperidinyl) ester, (2R,5R)-re l | C12H19N3O7S | 349.36 | | |
| 95 | 2650181-94-3 | Nalbuphine Impurity 12 | | | | |
| 96 | 2650183-89-2 | Tryptophan Impurity 73 | | | | |
| 97 | 2650185-60-5 | Otilonium Bromide Impurity 11 | | | | |
| 98 | 2650187-46-3 | Fezolinetant Impurity 9 | | | | |
| 99 | 2650188-32-0 | 5-Pyrimidinecarboxamide, 2-[[[2-(4-aminophenyl)-9-methyl-6-(4-morpholinyl)-9H-purin-8-yl]methyl]methylamino]-N-hydroxy-, methanesulfonate (1:1) | C24H30N10O6S | 586.63 | | |
| 100 | 2650189-14-1 | (2S,5R)-2-((R)-3-aminopyrrolidine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | C11H18N4O6S | 334.35 | | |
| 101 | 26502-09-0 | 3H,4H-3a,6a-Propano-1H-furo[3,4-c]pyrrole, dihydro- (8CI,9CI) | C9H15NO | 153.22 | | |
| 102 | 26502-55-6 | ethyl 4-hydroxy-1-(4-nitrophenyl)-1H-pyrazole-3-carboxylate | C12H11N3O5 | 277.23 | | |
| 103 | 26502-56-7 | ETHYL 1-(4-CHLOROPHENYL)-4-HYDROXY-1H-PYRAZOLE-3-CARBOXYLATE | C12H11ClN2O3 | 266.68 | | |
| 104 | 26502-58-9 | ETHYL 1-(4-ETHOXYPHENYL)-4-HYDROXY-1H-PYRAZOLE-3-CARBOXYLATE | C14H16N2O4 | 276.29 | | |
| 105 | 26502-92-1 | 3-Cyclopropyl-4,5-Dihydro-1H-Pyrazol-5-One | C6H8N2O | 124.14052 | | |
| 106 | 2650204-95-6 | Fazamorexant Impurity 14 | | | | |
| 107 | 2650205-80-2 | 2-(1H-imidazol-5-yl)-2-methylpropan-1-amine hydrochloride | C7H14ClN3 | 175.66 | | |
| 108 | 2650208-98-1 | ML370 | | | | |
| 109 | 2650213-59-3 | 4-Piperidinecarboxamide, 1-[2-(4-chlorophenyl)ethyl]-N-(6-methoxy-1,5-naphthyridin-4-yl)- | C23H25ClN4O2 | 424.92 | | |
| 110 | 2650218-22-5 | Fazamorexant Impurity 11 | | | | |
| 111 | 2650221-09-1 | 1-(5-(4-Methylpyridin-3-yl)-1H-indol-1-yl)ethanone | C16H14N2O | 250.3 | | |
| 112 | 2650244-55-4 | Cyclazosin Hydrochloride Impurity 8 | | | | |
| 113 | 2650253-86-2 | 2H-Indazole, 5-(1-butyl-1H-benzimidazol-2-yl)-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | C35H34N8 | 566.7 | | |
| 114 | 2650257-12-6 | Clacyfos Impurity 1 | | | | |
| 115 | 2650257-59-1 | Cyclazosin Hydrochloride Impurity 10 | | | | |
| 116 | 2650257-69-3 | Halopemide Impurity 111 | | | | |
| 117 | 2650263-26-4 | Cyclazosin Hydrochloride Impurity 4 | | | | |
| 118 | 2650265-89-5 | Cyclazosin Hydrochloride Impurity 6 | | | | |
| 119 | 2650285-53-1 | Safinamide Impurity | | | | |
| 120 | 26503-23-1 | 2-Methyl-4,5,6,7-tetrahydro-2H-indazol-3-aMine | C8H13N3 | 151.20892 | | |
| 121 | 26503-40-2 | 1-[2-[(Benzyloxy)methyl]butyl]-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole | C26H32N2O | 388.55 | | |
| 122 | 26503-54-8 | 13-Oxodelnudane-2α,6β-diol | C20H25NO3 | 327.42 | 235-237 °C | |
| 123 | 26503-91-3 | Carbonodithioic acid, O-[(4-chlorophenyl)methyl] S-(phenylmethyl) ester | C15H13ClOS2 | 308.85 | | |
| 124 | 2650303-14-1 | Halopemide Impurity 84 | | | | |
| 125 | 2650309-60-5 | 6-(Trifluoromethyl)-3,4-dihydro-1H-xanthene-1,9(2H)-dioneQ: What is 6-(Trifluoromethyl)-3,4-dihydro-1H-xanthene-1,9(2H)-dione Q: What is the CAS Number of 6-(Trifluoromethyl)-3,4-dihydro-1H-xanthene-1,9(2H)-dione | C14H9F3O3 | 282.22 | | |
| 126 | 2650317-02-3 | Cyclopamine Impurity 7 | | | | |
| 127 | 2650323-59-2 | Cyclazosin Hydrochloride Impurity 24 | | | | |
| 128 | 2650349-14-5 | Cyclopamine Impurity 60 | | | | |
| 129 | 2650371-66-5 | Halopemide Impurity 35 | | | | |
| 130 | 2650387-33-8 | 1,3-Cyclohexanedimethanamine, N1,N3-bis[[4-(1,1-dimethylethyl)phenyl]methyl]-, hydrochloride (1:1) | C30H47ClN2 | 471.17 | | |
| 131 | 2650393-56-7 | Halopemide Impurity 29 | | | | |
| 132 | 26504-29-0 | S,S-Dibenzyl trithiocarbonate | C15H14S3 | 290.47 | | |
| 133 | 2650403-99-7 | Halopemide Impurity 10 | | | | |
| 134 | 2650421-08-0 | Methacycline Hydrochloride Impurity 10 | | | | |
| 135 | 2650424-40-9 | Cerivastatin Sodium Impurity 128 | | | | |
| 136 | 2650424-60-3 | Halopemide Impurity 49 | | | | |
| 137 | 2650426-58-5 | Methyl 1-(1-phenylethyl)-1H-imidazole-4-carboxylate | C13H14N2O2 | 230.27 | | |
| 138 | 2650427-35-1 | LY-150720|||LY150720|||LY 150720 | | | | |
| 139 | 2650433-93-3 | Halopemide Impurity 5 | | | | |
| 140 | 2650435-92-8 | Halopemide Impurity 43 | | | | |
| 141 | 2650461-29-1 | Halopemide Impurity 52 | | | | |
| 142 | 2650463-76-4 | Halopemide Impurity 23 | | | | |
| 143 | 2650465-14-6 | Halopemide Impurity 64 | | | | |
| 144 | 2650469-63-7 | Halopemide Impurity 13 | | | | |
| 145 | 2650482-14-5 | Halopemide Impurity 47 | | | | |
| 146 | 2650489-61-3 | rel-Phenylmethyl (3R,4S)-3-ethyl-4-(2-hydroxyacetyl)-1-pyrrolidinecarboxylate | C16H21NO4 | 291.34 | | |
| 147 | 2650489-62-4 | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[1-[(trimethylsilyl)oxy]ethenyl]-, phenylmethyl ester, (3S,4R)- | C19H29NO3Si | 347.52 | | |
| 148 | 2650489-63-5 | Upadacitinib Impurity 44 | C16H21NO4 | 291.35 | | |
| 149 | 2650489-70-4 | Upadacitinib Impurity 61 | C21H23N5O2S | 409.51 | | |
| 150 | 2650492-10-5 | tetrahydrochloride | | | | |
| 151 | 26505-12-4 | 2-[(4-Hydrazinophenyl)-sulfonyl]-ethanol | C8H12N2O3S | 216.26 | | |
| 152 | 26505-36-2 | 2-Propenal, 3-(4-pyridinyl)- | C8H7NO | 133.15 | | |
| 153 | 26505-37-3 | 3,9-Bis[2-(dodecylthio)ethyl]-2,4,8,10-tetraoxaspiro[5.5]undecane | C35H68O4S2 | 617.04 | | |
| 154 | 26505-90-8 | 4',4''',5,5''-Tetrahydroxy-7,7''-dimethoxy-8,8''-biflavone | C32H22O10 | 566.51 | | |
| 155 | 2650510-14-6 | 9-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole | C24H23BClNO2 | 403.71 | | |
| 156 | 2650518-25-3 | 8H-1,2,4-Triazolo[3,4-c][1,4]oxazinium, 2-[4-(1,1-dimethylethyl)phenyl]-5,6-dihydro-5-(phenylmethyl)-, (5S)-, tetrafluoroborate(1-) (1:1) | C22H26BF4N3O | 435.27 | | |
| 157 | 2650519-91-6 | 3,6-bis(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)-9H-carbazole-1,2,4,5,7,8-d6 | | | | |
| 158 | 2650523-66-1 | Pyrido[2,3-d]pyrimidin-2(1H)-one, 7-(2-amino-6-fluorophenyl)-4-[(2S,5R)-4-(3-chloro-1-oxopropyl)-2,5-dimethyl-1-piperazinyl]-1-(4,6-dicyclopropyl-5-pyrimidinyl)-6-fluoro- | C32H33ClF2N8O2 | 635.11 | | |
| 159 | 2650530-00-8 | Acetic acid, 2-[(6-benzo[b]thien-2-ylthieno[3,2-d]pyrimidin-4-yl)thio]- | C16H10N2O2S3 | 358.46 | | |
| 160 | 2650530-01-9 | N-Cyclopentyl-5-[4-[(dimethylamino)carbonyl]-3-hydroxyphenyl]-N-methyl-3-isoxazolecarboxamide | C19H23N3O4 | 357.4 | | |
| 161 | 2650530-02-0 | SGC-BRDVIII-NC | | | | |
| 162 | 2650546-39-5 | 2-Piperazinone, 4-(cyclobutylcarbonyl)-1-[[2-(2-ethyl-1H-benzimidazol-1-yl)-9-methyl-6-(4-morpholinyl)-9H-purin-8-yl]methyl]- | C29H35N9O3 | 557.65 | | |
| 163 | 2650550-87-9 | 1,8-Naphthyridine-3-carbonitrile, 7-(3-chloro-2-fluoro-6-hydroxyphenyl)-6-fluoro-1,2-dihydro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-2-oxo-4-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]- | C31H27ClF2N6O3 | 605.03 | | |
| 164 | 2650557-72-3 | Isoquinoline, 6-fluoro-1,2,3,4-tetrahydro-2-[3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]phenyl]- | C27H28FN5 | 441.54 | | |
| 165 | 26506-24-1 | Pyridinium,1-methyl-2-[2-(2-pyridinyl)ethenyl]-, iodide (1:1) | C13H13IN2 | 324.16019 | | |
| 166 | 26506-47-8 | CUPRIC CHLORATE | ClCuHO3 | 148 | | |
| 167 | 2650601-11-7 | Didrovaltrate Impurity 4 | | | | |
| 168 | 2650604-05-8 | Mufemilast Impurity 7 | | | | |
| 169 | 2650604-06-9 | Mufemilast Impurity 6 | | | | |
| 170 | 2650604-07-0 | Mufemilast Impurity 9 | | | | |
| 171 | 2650604-08-1 | Mufemilast Impurity 22 | | | | |
| 172 | 2650604-09-2 | Mufemilast Impurity 21 | | | | |
| 173 | 2650604-10-5 | Mufemilast Impurity 17 | | | | |
| 174 | 2650604-11-6 | Mufemilast Impurity 8 | | | | |
| 175 | 2650604-12-7 | Mufemilast Impurity 16 | | | | |
| 176 | 2650605-07-3 | 5-Iodo-3-nitrophthalic Acid | | | | |
| 177 | 2650605-58-4 | 4H-Thieno[3,4-c]pyrrole-5(6H)-butanoic acid, γ-(aminocarbonyl)-1-(chloromethyl)-4-oxo-, 1,1-dimethylethyl ester | C16H21ClN2O4S | 372.87 | | |
| 178 | 2650605-59-5 | 4H-Thieno[3,4-c]pyrrole-5(6H)-butanoic acid, γ-(aminocarbonyl)-1-[[4-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]phenoxy]methyl]-4-oxo-, 1,1-dimethylethyl ester | C28H37N3O7S | 559.68 | | |
| 179 | 2650605-62-0 | 2,6-Piperidinedione, 3-[1-[[4-(aminomethyl)phenoxy]methyl]-4-oxo-4H-thieno[3,4-c]pyrrol-5(6H)-yl]- | C19H19N3O4S | 385.44 | | |
| 180 | 2650640-17-6 | Cyclohexanecarboxamide, N-[5-fluoro-4-(4-fluoro-2-methoxyphenyl)-2-pyridinyl]-3-[(2-hydroxyacetyl)amino]-, (1S,3R)- | C21H23F2N3O4 | 419.42 | | |
| 181 | 2650658-64-1 | Halopemide Impurity 38 | | | | |
| 182 | 2650670-41-8 | Bisoprolol EP Impurity C HCl/1-[4-[4-(2-Hydroxy-3-isopropopylaminopropoxy)-benzyl]phenoxy]- 3-isopropylaminopropan-2-ol hydrochloride | | | | |
| 183 | 2650678-39-8 | Halopemide Impurity 44 | | | | |
| 184 | 2650679-56-2 | 3-((benzyloxy)methyl)morpholine HCl | | | | |
| 185 | 2650687-67-3 | Oxolamine Impurity 73 | | | | |
| 186 | 26507-91-5 | 2-METHOXY-3-METHYLBENZOIC ACID | C9H10O3 | 166.17 | 83 °C | |
| 187 | 2650726-60-4 | Halopemide Impurity 25 | | | | |
| 188 | 2650733-69-8 | Clathrin-IN-2 | C17H18Br2N2O | 426.15 | | |
| 189 | 2650737-35-0 | Halopemide Impurity 69 | | | | |
| 190 | 2650741-85-6 | Halopemide Impurity 46 | | | | |
| 191 | 2650742-72-4 | 2650742-72-4 | C15H23ClN2O | 282.81 | | |
| 192 | 2650749-23-6 | JNJ 7706621 Impurity 14 | | | | |
| 193 | 2650775-01-0 | Halopemide Impurity 6 | | | | |
| 194 | 2650788-81-9 | Halopemide Impurity 61 | | | | |
| 195 | 26508-25-8 | 6α-[(R)-Phenyl[(trimethylsilyl)amino]acetylamino]penicillanic acid trimethylsilyl ester | C22H35N3O4SSi2 | 493.77 | | |
| 196 | 26508-33-8 | FERRIC PHOSPHIDE | FeP | 86.82 | | |
| 197 | 26508-36-1 | 2-[[α-[Hydroxy(octyloxy)phosphinyl]benzyl]amino]benzoic acid | C22H30NO5P | 419.45 | | |
| 198 | 2650806-35-0 | Mequitazine Impurity 21 | | | | |
| 199 | 2650807-32-0 | Gedatolisib Impurity 148 | | | | |
| 200 | 2650808-96-9 | A 922500 Impurity 12 | | | | |
| 201 | 2650833-09-1 | Halopemide Impurity 124 | | | | |
| 202 | 2650844-30-5 | Ilorasertib Impurity 14 | C26H23FN6O2S | 502.57 | | |
| 203 | 2650846-59-4 | OSM-S-106 | C12H10N4O2S2 | 306.37 | | |
| 204 | 2650850-95-4 | Halopemide Impurity 129 | | | | |
| 205 | 2650852-20-1 | Doramapimod Impurity 29 | | | | |
| 206 | 2650852-57-4 | 1H-Indole-5,6-dione, 2,3-dihydro-3-hydroxy-, (3S)- | C8H7NO3 | 165.15 | | |
| 207 | 2650867-04-0 | Mesopram Impurity 11 | | | | |
| 208 | 2650885-46-2 | tert-butyl (R)-2-((tert-butoxycarbonyl)amino)-2-(naphthalen-2-yl)acetate | C21H27NO4 | 357.45 | | |
| 209 | 2650892-58-1 | Oxolamine Impurity 173 | | | | |
| 210 | 2650898-66-9 | Didrovaltrate Impurity 12 | | | | |
| 211 | 26509-45-5 | METHYLEUGENOLGLYCOL | C11H16O4 | 212.24 | 67.5-69℃ | |
| 212 | 26509-71-7 | (E)-3,7-dimethylocta-3,6-dienenitrile | C10H15N | 149.23 | | |
| 213 | 26509-72-8 | (Z)-3,7-dimethylocta-3,6-dienenitrile | C10H15N | 149.23 | | |
| 214 | 2650917-30-7 | 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-N-methylbenzamide | C16H25N3O4S | 355.45 | | |
| 215 | 2650918-08-2 | Ilorasertib Impurity 24 | C27H26N6O2S | 498.61 | | |
| 216 | 2650944-83-3 | FATP1-IN-2 | C19H20FN5O | 353.39 | | |
| 217 | 265097-87-8 | Hexanedioic acid polymer with 5-amino-1,3,3-trimethylcyclohexane methanamine, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, methyloxirane, 3-methyl-1,5-pentanediol and oxirane | C39H74N4O10 | 759.04 | | |
| 218 | 265098-01-9 | 2H-Indol-2-one, 3-[(3,5-dichloro-4-hydroxyphenyl)methylene]-5-(2-furanylcarbonyl)-1,3-dihydro- | C20H11Cl2NO4 | 400.21 | | |
| 219 | 265098-90-6 | butyl (Z)-4-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)butanoate | C18H21NO3S2 | 363.49 | | |
| 220 | 265098-91-7 | pentyl (Z)-4-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)butanoate | C19H23NO3S2 | 377.52 | | |
| 221 | 265098-95-1 | butyl (Z)-4-(5-(4-methoxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)butanoate | C19H23NO4S2 | 393.52 | | |